Rational design and pairing of single-domain antibodies for developing rapid detection methods for botulinum neurotoxins A and B.

Analytica chimica acta 2025 Vol.1354() p. 343977

Lv R, Li J, Fang X, Tang L, Shi R, Wang J, Zhang W, Wang J, Zhao G, Wang J, Gao S, Xu X, Kang L, Xin W

관련 도메인

Abstract

[BACKGROUND] Botulinum neurotoxin (BoNT) is a toxin produced by Clostridium botulinum that can cause neurological dysfunction in humans and animals, with BoNT/A and BoNT/B being responsible for the majority of poisoning cases. Due to its extremely high toxicity, BoNT is considered a potential biological warfare and bioterrorism agent. Currently, there is a lack of rapid and highly sensitive detection methods for botulinum toxin, making the development of fast and effective detection methods for BoNT essential. Here, we developed rapid detection methods for BoNT/A and BoNT/B based on nanobodies, including two ELISA methods and Time-resolved fluorescence immunochromatography assay (TRFICA).

[RESULTS] By analyzing the binding epitopes of BoNT/A, BoNT/B, and nanobodies, we rationally designed and prepared six nanobodies, adding a Trx tag at the N-terminus, a 6 × His tag at the C-terminus, and fusing them with HRP, for use in developing two ELISA methods for BoNT/A and BoNT/B detection. Additionally, TRFICA was developed in combination with lanthanide microspheres. These three methods were validated using simulated samples containing BoNT in milk, sand, and human serum. The limits of detection for ELISA 1 and 2 were 0.17 and 4.5 ng/mL, respectively, while the TRFICA had a detection limit of 0.05 ng/mL and provided results in approximately 15 min. TRFICA also successfully detected clinical samples, with a sensitivity of 98 % and a specificity of 96.7 %.

[SIGNIFICANCE] Overall, the TRFICA method we established has a short detection time, is easy to operate, and effectively addresses the challenge of rapid BoNT detection in clinical diagnostics, with significant clinical application value. Furthermore, based on the sequences and binding epitopes of nanobodies, we rationally designed six nanobodies and successfully applied them in the development of various BoNT detection methods. This approach and pipeline provide valuable guidance for the future development of rapid, low-cost detection methods.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 milk scispacy 1
약물 BoNT/A scispacy 1
약물 [BACKGROUND] Botulinum neurotoxin scispacy 1
약물 [RESULTS] scispacy 1
약물 lanthanide microspheres scispacy 1
질환 Clostridium botulinum C0009055
Clostridium botulinum
scispacy 1
질환 neurological dysfunction C0027767
Nervous System Physiological Phenomena
scispacy 1
질환 poisoning C0032343
Poisoning
scispacy 1
질환 toxicity C0040539
Toxicity aspects
scispacy 1
기타 Clostridium botulinum scispacy 1
기타 humans scispacy 1
기타 BoNT/A scispacy 1
기타 BoNT/B scispacy 1
기타 BoNT → Botulinum neurotoxin scispacy 1
기타 nanobodies scispacy 1
기타 Trx scispacy 1
기타 HRP scispacy 1
기타 human serum scispacy 1

MeSH Terms

Single-Domain Antibodies; Botulinum Toxins, Type A; Enzyme-Linked Immunosorbent Assay; Humans; Botulinum Toxins; Animals; Limit of Detection; Chromatography, Affinity; Milk

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문